Filings & corporate actions
62 results filed
CSVNext results · Q2 FY27
Expected 4 Nov 2026 – 11 Nov 2026
Estimate: filed 35–42 days after quarter end, last 5 times
Dividend
₹12.00 per share · last 29 Jul 2026
2026
- 4 AugresultsResults · Q1 FY27 · consolidated and standalone+1.1%NSE
- 29 JuldividendDividend · ₹12.00 per share-0.8%
- 15 JulshareholdingShareholding · 30 Jun 2026+3.5%NSE
- 15 MayresultsResults · Q4 FY26 · consolidated and standalone-7.6%NSE
- 10 AprshareholdingShareholding · 31 Mar 2026+0.6%NSE
- 5 FebresultsResults · Q3 FY26 · consolidated and standalone-1.6%NSE
- 9 JanshareholdingShareholding · 31 Dec 2025-1.8%NSE
Reaction to results · all yearsrose on day 0 in 17 of 60 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 4 Aug 2026 | +1.1% | +4.0% | +2.2% | 2.4× |
| Q4 FY26 | 15 May 2026 | -7.6% | -2.8% | -4.9% | 2.1× |
| Q3 FY26 | 5 Feb 2026 | -1.6% | -5.0% | -12.9% | 1.9× |
| Q2 FY26 | 4 Nov 2025 | -4.7% | -4.7% | -6.1% | 2.3× |
| Q1 FY26 | 5 Aug 2025 | +0.2% | -0.4% | 0.0% | 1.2× |
| Q4 FY25 | 6 May 2025 | +1.1% | +2.4% | +10.7% | 0.3× |
| Q3 FY25 | 3 Feb 2025 | -2.9% | -4.3% | -11.4% | 1.3× |
| Q2 FY25 | 7 Nov 2024 | -3.9% | -5.1% | +2.3% | 1.1× |
| Q1 FY25 | 8 Aug 2024 | -6.9% | -11.8% | -0.9% | 0.5× |
| Q4 FY24 | 9 May 2024 | -2.6% | -4.1% | -8.5% | 1.5× |
| Q3 FY24 | 5 Feb 2024 | +2.2% | +2.9% | +4.1% | 0.8× |
| Q2 FY24 | 7 Nov 2023 | -1.0% | +2.1% | +3.8% | 1.7× |
| Q1 FY24 | 4 Aug 2023 | +1.7% | +1.3% | -0.3% | 0.7× |
| Q4 FY23 | 5 May 2023 | +6.9% | +1.1% | -0.1% | 10.2× |
| Q3 FY23 | 1 Feb 2023 | +0.2% | -3.3% | -6.7% | 1.9× |
| Q2 FY23 | 11 Nov 2022 | +0.1% | -2.2% | -6.6% | 0.5× |
| Q1 FY23 | 4 Aug 2022 | -4.3% | -6.4% | -9.8% | 6.2× |
| Q4 FY22 | 3 May 2022 | -6.7% | -7.5% | -6.8% | 6.4× |
| Q3 FY22 | 10 Feb 2022 | -0.8% | -7.7% | -3.9% | 0.6× |
| Q2 FY22 | 10 Nov 2021 | -3.3% | -4.4% | +1.9% | 4.3× |
| Q1 FY22 | 26 Jul 2021 | -11.2% | -13.6% | -17.8% | 13.9× |
| Q4 FY21 | 5 May 2021 | -5.0% | -5.5% | -5.2% | 3.5× |
| Q3 FY21 | 19 Jan 2021 | -3.6% | -11.0% | -10.4% | 3.8× |
| Q2 FY21 | 22 Oct 2020 | -3.8% | -4.7% | -1.9% | 2.5× |
| Q1 FY21 | 22 Jul 2020 | -3.9% | -1.4% | -1.9% | 3.8× |
| Q4 FY20 | 22 May 2020 | -3.6% | -5.3% | +3.0% | 0.7× |
| Q3 FY20 | 22 Jan 2020 | -0.2% | +8.4% | +12.6% | 1.9× |
| Q2 FY20 | 24 Oct 2019 | -0.6% | +6.7% | +2.2% | 24.6× |
| Q1 FY20 | 29 Jul 2019 | -4.9% | -2.2% | -6.0% | 1.3× |
| Q4 FY19 | 9 May 2019 | -1.0% | -2.1% | -7.2% | 0.5× |
| Q3 FY19 | 23 Jan 2019 | -0.2% | +1.5% | -10.5% | 0.6× |
| Q2 FY19 | 23 Oct 2018 | -0.4% | +1.9% | -2.5% | 1.4× |
| Q1 FY19 | 7 Aug 2018 | +3.0% | +0.9% | +8.2% | 0.8× |
| Q4 FY18 | 25 May 2018 | +0.7% | -0.5% | +21.7% | 0.8× |
| Q3 FY18 | 16 Mar 2018 | -0.7% | -1.4% | -6.0% | 0.5× |
| Q2 FY18 | 8 Nov 2017 | 0.0% | 0.0% | +0.3% | 0.3× |
| Q4 FY17 | 30 Oct 2017 | +2.6% | +2.7% | +2.8% | 0.7× |
| Q1 FY18 | 4 Aug 2017 | +0.2% | -2.9% | -4.8% | 0.3× |
| Q3 FY17 | 30 Jan 2017 | -0.3% | -0.6% | +2.7% | 1.2× |
| Q2 FY17 | 8 Nov 2016 | -0.2% | -7.1% | -3.9% | 0.5× |
| Q1 FY17 | 1 Oct 2016 | +1.8% | +2.8% | +2.6% | 0.8× |
| Q4 FY16 | 29 Apr 2016 | -1.1% | -2.2% | -11.6% | 1.3× |
| Q3 FY16 | 22 Jan 2016 | +1.2% | +0.4% | -1.4% | 2.8× |
| Q2 FY16 | 29 Oct 2015 | -0.1% | -1.6% | +3.7% | 1.0× |
| Q1 FY16 | 3 Aug 2015 | +0.4% | -8.8% | -5.1% | 0.8× |
| Q4 FY15 | 9 May 2015 | -0.1% | +8.6% | +16.7% | 0.2× |
| Q3 FY15 | 7 Feb 2015 | -4.1% | +1.4% | +4.5% | 2.5× |
| Q2 FY15 | 27 Oct 2014 | -4.0% | -4.5% | -0.8% | 0.7× |
| Q1 FY15 | 5 Aug 2014 | -1.8% | -7.2% | +8.0% | 0.8× |
| Q4 FY14 | 2 May 2014 | -3.1% | -10.6% | -15.6% | 0.4× |
| Q3 FY14 | 24 Jan 2014 | -2.3% | -2.2% | +8.4% | 0.5× |
| Q2 FY14 | 22 Nov 2013 | -1.4% | +1.0% | +4.5% | 0.3× |
| Q1 FY14 | 13 Aug 2013 | -1.8% | -15.8% | -12.5% | 0.2× |
| Q4 FY13 | 23 May 2013 | -1.5% | +13.9% | +11.0% | 0.2× |
| Q3 FY13 | 21 Jan 2013 | -1.1% | +8.7% | +8.5% | 2.3× |
| Q2 FY13 | 19 Oct 2012 | +2.8% | -4.4% | -9.7% | 2.5× |
| Q1 FY13 | 9 Aug 2012 | -4.8% | -2.6% | +16.4% | 2.7× |
| Q4 FY12 | 3 May 2012 | -3.1% | -3.9% | -9.8% | 0.6× |
| Q3 FY12 | 8 Feb 2012 | -0.4% | +9.1% | +5.0% | 2.1× |
| Q2 FY12 | 19 Oct 2011 | +1.0% | -0.1% | -12.1% | 2.3× |
| Average | -1.5% | -1.8% | -1.1% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+25.7%
Profit YoY+12.2%
Interest cost YoY+9.7%
Revenue QoQ+16.3%
Profit QoQ-14.5%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +11.1% | +9.8% | — | +7.7% | +7.7% | +9.9% |
| Profit | +4.6% | +9.3% | — | -7.4% | -5.6% | +1.7% |
Key data
CSVOpen831.25
Day range825.00 – 840.30
52-week range635.80 – 998.00
From 52w high-16.4%
RSI (14)50.9
ATR (14)26.16
Volume1.43L
Avg volume (20D)2.44L
Rel volume0.59×
Volatility (1Y)27.1%
Turnover₹11.9Cr
SMA 50 / 200825.22 / 782.38
Delivery percentage
Latest · 6 Oct 202661.6%
20-day avg50.6%
1-year avg47.0%
Percentile (own history)84th
Range5.2–96.8%
Sessions1,731
Over the last 20 sessions APLLTD settled 50.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 47.0%, so recent sessions are running 3.6 points higher than usual. The latest session ranks higher than 84% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryPharmaceuticals
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.35% | -2.36% | +3.80% | +0.58% | +27.13% | -8.32% |
Valuation
CSVMarket cap₹16,397 Cr
P/E (TTM)23.8
EPS (TTM)35.08
Shares outstanding19.66Cr
Listed20 Sept 2011
Ownership
CSVPromoter69.87%
Promoter Δ QoQ+0.13 pp
Public30.13%
FII4.18%
DII15.94%
Pledged0.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 1,910.2 | 1,876.3 | 1,847.7 | 2,149.8 |
| YoY chg | +15.9% | +10.8% | +4.4% | +25.7% |
| Net profit (₹ Cr) | 183.7 | 132.0 | 201.5 | 172.4 |
| YoY chg | +20.0% | -4.2% | +28.7% | +12.2% |
| Net margin | 9.6% | 7.0% | 10.9% | 8.0% |
| EPS | 9.40 | 6.76 | 10.31 | 8.80 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 69.87% · public 30.13%2021-092026-06
- Promoter
- Public and others
- Promoter
- 69.87%
- Public
- 30.13%
- Promoter change
- +0.13 pp
- Filed
- 15 Jul 2026
- FII
- 4.18%
- DII
- 15.94%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,594.9 | 1,630.6 | 1,517.0 | 1,561.7 | 1,648.0 | 1,692.7 | 1,769.6 | 1,710.7 | 1,910.2 | 1,876.3 | 1,847.7 | 2,149.8 | |
| Other income | 10.2 | 2.9 | 3.6 | 2.1 | 16.7 | 9.5 | 14.2 | 6.5 | 6.9 | 15.5 | 25.5 | 14.9 | |
| Total income | 1,605.1 | 1,633.5 | 1,520.6 | 1,563.8 | 1,664.7 | 1,702.2 | 1,783.8 | 1,717.2 | 1,917.1 | 1,891.8 | 1,873.2 | 2,164.7 | |
| Total expenses | 1,469.9 | 1,448.8 | 1,337.3 | 1,407.1 | 1,498.0 | 1,524.8 | 1,591.2 | 1,526.7 | 1,694.8 | 1,686.2 | 1,730.9 | 1,943.2 | |
| └ Finance costs | 15.7 | 15.2 | 10.9 | 13.2 | 18.8 | 22.3 | 24.5 | 23.5 | 24.2 | 23.3 | 22.6 | 27.6 | |
| └ Depreciation | 67.6 | 69.4 | 69.5 | 69.0 | 70.5 | 70.0 | 69.0 | 73.8 | 76.1 | 80.1 | 88.6 | 97.7 | |
| Profit before tax | 135.1 | 184.6 | 183.2 | 156.7 | 179.6 | 177.4 | 192.6 | 190.6 | 222.3 | 163.3 | 117.5 | 221.5 | |
| Tax expense | (1.9) | 4.1 | 4.6 | 22.5 | 27.3 | 40.1 | 35.3 | 36.5 | 40.0 | 29.6 | (82.9) | 49.5 | |
| Net profit | 136.6 | 180.5 | 178.2 | 134.5 | 153.1 | 137.7 | 156.6 | 153.6 | 183.7 | 132.0 | 201.5 | 172.4 | |
| EPS | 6.95 | 9.18 | 9.07 | 6.85 | 7.79 | 7.01 | 7.98 | 7.85 | 9.40 | 6.76 | 10.31 | 8.80 | |
| Net margin | 8.56% | 11.07% | 11.75% | 8.61% | 9.29% | 8.13% | 8.85% | 8.98% | 9.62% | 7.03% | 10.91% | 8.02% | |
| PBT margin | 8.47% | 11.32% | 12.08% | 10.03% | 10.90% | 10.48% | 10.88% | 11.14% | 11.64% | 8.71% | 6.36% | 10.30% | |
| Tax rate | -1.42% | 2.23% | 2.53% | 14.35% | 15.19% | 22.59% | 18.33% | 19.14% | 17.99% | 18.09% | -70.55% | 22.35% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 4 Aug 2026.
APLLTD at a glance
- APLLTD closed at ₹834.2 on 6 Oct 2026, +0.35% on the day, -8.3% over one year, 16.4% below its 52-week high of ₹998.
- Delivery was 61.6% of traded quantity on 6 Oct 2026, the 84th percentile of its own 1,731 sessions with a reading (20-session average 50.6%, 1-year average 47.0%).
- Market capitalisation is ₹16,397 crore at a trailing P/E of 23.8 (trailing EPS ₹35.08).
- Q1 FY27 results (consolidated, filed 4 Aug 2026): revenue ₹2,150 crore (+25.7% year on year), net profit ₹172 crore (+12.2%); the price moved +1.1% on the first session after.
- Promoters held 69.87% at 30 Jun 2026, up 0.13 percentage points on the previous filing.
- Q2 FY27 results are expected between 4 Nov 2026 and 11 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryPharmaceuticals
ISININE901L01018
SeriesEQ
Listed20 Sept 2011
History from20 Sept 2011
Sessions3,724
Turnover rank#766
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Pharmaceuticals & Biotechnology
CSV- DIVISLABDivi's Laboratories Limited9,550.00+3.85%
- LAURUSLABSLaurus Labs Limited2,050.00+3.99%
- SUNPHARMASun Pharmaceutical Industries Limited1,804.10+1.37%
- WOCKPHARMAWockhardt Limited2,176.40+5.47%
- DRREDDYDr. Reddy's Laboratories Limited1,208.00+0.42%
- MOREPENLABMorepen Laboratories Limited143.96+6.41%
- ZYDUSLIFEZydus Lifesciences Limited1,159.50+1.80%
- SYMBIOTECSYMBIOTEC1,149.50-1.73%
- TORNTPHARMTorrent Pharmaceuticals Limited4,772.000.00%
- GLANDGland Pharma Limited3,006.10+3.25%
- LUPINLupin Limited2,029.30+0.91%
- AUROPHARMAAurobindo Pharma Limited1,692.80+1.07%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE